Korify Capital invests in late stage/pre IPO venture opportunities and makes opportunity-driven investments in smaller companies.
The firm has a strong focus on the biotech sector in the United States, Europe and Israel, but also selectively invests in fintech and blockchain opportunities.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Sep 2, 2021 | Korify Capital Fund ONE | - | |
Korify Capital AG | - |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 25, 2022
Alto Neuroscience
|
Series B | $35M | Artificial Intelligence | — |
Sep 14, 2022
Gameto
|
Series Unknown | $17M | Biopharma | — |
Jan 26, 2022
Storypod
|
Seed | $4M | Children | — |
Oct 26, 2021
Cambrian Biopharma
|
Series C | $100M | Biopharma | — |
Aug 12, 2021
Wonder brands
|
Seed | $20M | Consumer Goods | — |
Korify Capital has had 2 exits. Korify Capital most notable exits include ATAI Life Sciences , Sensei Biotherapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 17, 2021 | ATAI Life Sciences | IPO | Biotechnology | Detail |
Feb 3, 2021 | Sensei Biotherapeutics | IPO | Biotechnology | Detail |